Journals / Toplum ve Hekim / 2011 / Cilt: 26 - Sayı: 4

Example of global public-private partner ship in health: GAVI

Küresel kamu-özel sağlık işbirliği örneği: GAVI (Global alliance for vaccines and ımmunization)

Pages
297–307
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The losers are the children, the mothers and all the other parts of the community in need of vaccines but who are unable to access them as well as the future generations who are under the mortgage of loans.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It is necessary to examine the historical background, methods and actors of GAVI in order to understand how the dynamics of this international public private partnership is woven, how the market's needs are lead, how the demand is inflated and the tools of this procedure.
📊
Key Findings & Data:It is clear that, this procedure is not favoring public and increasing the profitability and the production capacity of private sector and aiming to increase it more.
💡
Conclusion & Impact:The losers are the children, the mothers and all the other parts of the community in need of vaccines but who are unable to access them as well as the future generations who are under the mortgage of loans.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

It is necessary to examine the historical background, methods and actors of GAVI in order to understand how the dynamics of this international public private partnership is woven, how the market's needs are lead, how the demand is inflated and the tools of this procedure. With this examination, it becomes obvious what kind of a scenario is this systematically woven trade network the product of and how the global profit targets and benefits of international giant companies are administered via GAVI on the poor countries with already very low public resources. In this public private partnership, GAVI fullfills its role apropriately. It is clear that, this procedure is not favoring public and increasing the profitability and the production capacity of private sector and aiming to increase it more. In the low resourced countries because buying or being able to buy, means loans, the global actors of finance, appear and they take their part among the actors who profit from this procedure together with the giant vaccine industry. The losers are the children, the mothers and all the other parts of the community in need of vaccines but who are unable to access them as well as the future generations who are under the mortgage of loans.

Özet

Ulusal aşı pazarlarının uluslararası bir kamu-özel ortaklığının dinamikleriyle nasıl örüldüğünü, pazarın gereksinimlerinin nasıl yönetilip, istenilen yönde talebin nasıl şişirildiğini ve bu sürecin aygıtlarını anlamak için GAVI'nin tarihsel gelişimini, yöntemlerini ve aktörlerini incelemek gerekir. Bu incelemeyle, sistematik olarak örülen bu ticari ağın nasıl bir senaryonun ürünü olduğu, kamusal kaynakların zaten son derece kısıtlı olduğu yoksul ülkelerde, dev ulus ötesi aşı üreticilerinin küresel kar hedeflerinin ve çıkarlarının GAVI tarafından nasıl yönetildiği netleşmektedir. Bu kamu-özel işbirliği örneğinde, GAVI rolünü layıkıyla yerine getirmektedir. Sürecin kamu lehinde gelişmediği ve özel sektörün hem karlılığını, hem de üretim kapasitesini istenilen düzeylere yükselttiği ve daha da yükseltmeyi umduğu ortadadır. Kaynakları kısıtlı yoksul ülkelerde, almak, alabilmek "borç" demek olduğu için, küresel pazarın finans aktörleri devreye girmekte ve aşı devleri yanı sıra bu aktörler de süreçten karlı çıkanlar arasına katılmaktadır. Kaybedenler, yoksul ülkelerin aşıya erişemeyen çocukları, anneleri, tüm aşı ihtiyacı olan bireyleri ve borçlarla ipotek altına giren gelecek nesilleri olmaktadır.

🔖

Cite This Article

ERGİN, I. (2011). Example of global public-private partner ship in health: GAVI. Toplum ve Hekim, Cilt: 26 - Sayı: 4, 297–307. https://ajindex.com/articles/367714

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Aksakoğlu, G. (2003) "Uluslar arası sermaye ve Bağışıklama pazarı" Toplum ve Hekim Eylül Ekim 2003 Cilt 18 Sayı 5 sf: 323-330
  2. Copenhagen Consensus (2008)
  3. Frederiksberg, Denmark; 2008; The outcome of Copenhagen Consensus 2008.http://www. copenhagencon sensus.com /Home.aspx GAVI (2010) GAVI Alliance Progress Report 2009.
  4. GAVI Alliance, ATAR ROTO PRESSE SA. GAVI (2008 "New vaccines co-financing Q & A, 2008" GA V I Alliance Secretariat. GAVI Alliance, (2010) "Investing in immunisation through the GAVI Alliance,The evidence base, 2010"www.gavialliance.org (Erişim tarihi: 25 Mart 2011)
  5. GIVS (2005) "Global Immunization Vision and Strategy 2006-2015"
  6. WHO Department of Immunization, Vaccines and Biologicals and UNICEF Programme Division, Health Section, WHO/IVB/ 05.05,2005
  7. Kaddar, M., Lydon, P., Levine, R. (2004) "Financial challenges of immunization: a look at GAVI." Bull World Health Organ. Sep;82(9):697-702.
  8. Lydon, P., Levine, R, Makinen, M., Brenzel, L., Mitchell, V., Milstien, JB., Kamara, L., Landry, S. (2008/1) "Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?" Vaccine. 2;26(51 ):6706-16. (1) Lydon, P., Beyai, PL., Chaudhri, I., Cakmak, N., Satoulou, A., Dumolard, L. (2008/2) "Government financing for health and specific national budget lines: the case of vaccines and immunization." Vaccine. 2;26(51 ):6727-34.(2) Milstien, J.B., Kamara, L., Lydon, P., Mitchell, V., Landry, S. (2008) "The GAVI Financing Task Force: one model of- partner collaboration." Vaccine. 2;26(51 ):6699-705.
  9. Plotkin, S.L., Plotkin, S.A. (2008) A short history of vaccination, "Plotkin S, Orenstein W, Offit P (eds).Vaccines" Saunders Elsevier. 307 Schwartz, ]B., Bhushan, I. (2004) "Improving immunization equity through a public-private partnership in Cambodia." Bull World Health Organ. Sep;82(9):661-7.
  10. WHO (2002) "State of the World's Vaccines and Immunization" WHO, UNICEF, WB. http:// www.who.int/vaccines/en/sowvi2002.shtml (WHO, 2005) "WHO Immunization Coverage Estimates and Trajectories (WHO ICE-T)". Web Annex 1: Trajectories for Scaling Up Immunization (WHO ICE-T). Department of Immunization, Vaccines and Biologicals, Geneva, Switzerland. WHO UNICEF (2005) WHO UNICEF guidelines for developing a comprehensive multiyear plan(cMYP) World Health Organization Department of Immunization, Vaccines and Biologicals WHO/IVB/ 05.20. Geneva 27, Switzerland. WHO- UNICEF-World Bank (2009) "State of the world's vaccines